In August 2023 the Athletics Integrity Unit (AIU), on behalf of World Athletics, reported and anti-doping rule violation against the Kenyan Athlete Salina Jebet after her sample tested positive for the prohibited substance 19-norandrosterone (Nandrolone).
Following notification a provisional suspension was ordered. The Athlete responded and filed a statement in her defence.
The Athlete explained that she underwent medical treatment for her diagnosed condition. In support she submitted medical information and a prescription issued by the Kapsabet County Referral Hospital.
Hereafter the AIU requested assistance from the Anti-Doping Agency of Kenya (ADAK) with an investigation into the Athlete's explanations and supporting medical documents. In October 2023 ADAK's investigation revealed that the filed medical documents from the clinic were falsifications.
The Hospital confirmed that the Athlete had only visited the hospital in August 2023. Yet, no prescription had ever been issued, nor was an injection administered, nor was the medication Nandrolone in stock in the hospital.
Consequently in May 2024 the AIU reported two anti-doping rule violations against the Athlete for:
- presence of a prohibited substance; and
- tampering with any part of the doping control.
After notification of these charges the Athlete gave a timely admission and she accepted the sanction proposed by the AIU. The AIU considers that the Athlete has failed to demonstrate that these two violations were not intentional, nor any exceptional circumstances for a reduced sanction.
Because the Athlete had signed and submitted the Admission of Anti-Doping Rule Violation and Acceptance of Consequences Form in July 2024 she received a 1 year reduction from the AIU.
Therefore the AIU decides on 2 July 2024 to impose a 7 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 17 August 2023.
